Skip to content

Welcome to Discover Pharma! Today is : October 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

p-Tau217

  • Central Nervous System,Genomics and sequencing,Research & Development,Therapeutic Areas

    Alamar expands Alzheimer’s proteomics partnership with 86,000 more samples

    Alamar Biosciences is expanding a partnership with the Alzheimer’s Disease [...]

    August 12, 2026
  • Digital & Data,Medical devices,Therapeutic Areas

    Sysmex launches automated Alzheimer’s blood testing platform in Europe

    Sysmex Europe has launched its HISCL automated immunoassay platform for [...]

    June 17, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Aravax to present Phase 2 peanut allergy data in November
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • CPHI Milan to focus on practical sustainability across pharma supply chains
    Categories: Manufacturing & Supply Chain, Opinion & Events
  • Brenntag and dsm-firmenich agree global GMP vitamin deal
    Categories: Clinical & Regulatory
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top